Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of chronic insomnia disorder in adults. METHODS: This guideline is based on a systematic review of randomized, controlled trials published in English from 2004 through September 2015. Evaluated outcomes included global outcomes assessed by questionnaires, patient-reported sleep outcomes, and harms. The target audience for this guideline includes all clinicians, and the target patient population includes adults with chronic insomnia disorder. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. RECOMMENDATION 1: ACP recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for chronic insomnia disorder. (Grade: strong recommendation, moderate-quality evidence). RECOMMENDATION 2: ACP recommends that clinicians use a shared decision-making approach, including a discussion of the benefits, harms, and costs of short-term use of medications, to decide whether to add pharmacological therapy in adults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone was unsuccessful. (Grade: weak recommendation, low-quality evidence).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended first-line treatment for insomnia disorder, including among individuals with comorbid psychiatric conditions”
From Benefits of Cognitive Behavioral Therapy for Insomnia for Women Veterans with and without Probable Post-Traumatic Stress Disorder (2022) · cites this paper as Qaseem, Kansagara, Forciea, Cooke, & Denberg, 2016
In the citing paper
“Insomnia is, however, highly treatable with cognitivebehavioral therapy for insomnia (CBT-I), a behavioral medicine intervention well-established as the treatment of choice for cancer-related sleep disturbances due to its efficacy, long-lasting benefits, and security profile. 12,13”
From Digital Cognitive-Behavioral Therapy for Insomnia in Cancer Survivors: Protocol for a Pragmatic Clinical Trial (2024) · cites this paper as [12]
In the citing paper
“CBT-I, in particular, has been established as the first-line treatment because of its efficacy and minimal adverse effects compared with those associated with medication (22).”
From Interventions for insomnia in cancer patients and survivors-a comprehensive systematic review and meta-analysis (2024) · cites this paper as [22]
In the citing paper
“The first-line recommended treatment for insomnia disorder, Cognitive-Behavioral Therapy for Insomnia (CBT-I)”
From Novel Treatment Based on Acceptance and Commitment Therapy Versus Cognitive Behavioral Therapy for Insomnia: A Randomized Comparative Effectiveness Trial in Women Veterans (2023) · cites this paper as Qaseem et al., 2016
In the citing paper
“has been shown to improve insomnia symptoms for most patients, including those with comorbid conditions”
From Novel Treatment Based on Acceptance and Commitment Therapy Versus Cognitive Behavioral Therapy for Insomnia: A Randomized Comparative Effectiveness Trial in Women Veterans (2023) · cites this paper as Qaseem et al., 2016
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
International Classification of Sleep Disorders-Third Edition
Sateia, M. J. (2014) · Chest · doi:10.1378/chest.14-0970 · Cited by 3,860
Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095
Morin, C. M., & Benca, R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60750-2 · Cited by 976
Buysse, D. J. (2013) · JAMA · doi:10.1001/jama.2013.193 · Cited by 965
Krystal, A. D., Walsh, J. K., Laska, E., Caron, J., Amato, D. A., Wessel, T. C., & Roth, T. (2003) · Sleep · doi:10.1093/sleep/26.7.793 · Cited by 630
Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. (2001) · JAMA · doi:10.1001/jama.285.14.1856 · Cited by 625
Sivertsen, B., Omvik, S., Pallesen, S., Bjorvatn, B., Havik, O. E., Kvale, G., Nielsen, G. H., & Nordhus, I. H. (2006) · JAMA · doi:10.1001/jama.295.24.2851 · Cited by 589
Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.17.1888 · Cited by 579
Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. L. (2012) · Sleep · doi:10.5665/sleep.1872 · Cited by 550 · cited 1×
“Improvements were seen across the various methods of CBT-I delivery, including in-person individual therapy (18, 24, 33, 35, 36), in-person group therapy (19, 20, 31), telephone-based modules (21), Web-based modules (17, 22, 23, 25), and self-help books (26, 29, 37); however, evidence was insufficient to determine the…”
MethodEfficacy of Brief Behavioral Treatment for Chronic Insomnia in Older Adults
Buysse, D. J., Germain, A., Moul, D. E., Franzen, P. L., Brar, L. K., Fletcher, M. E., Begley, A., Houck, P. R., Mazumdar, S., Reynolds, C. F., et al. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.535 · Cited by 548
Research works printed but not linked: 5
- 10.1037/0022-006x.67.4.511 · doi:10.1037/0022-006x.67.4.511 · Paper page
- Morgan K, 2003, Br J Gen Pract, 53, 923
- 10.1037/0022-006x.61.1.137 · doi:10.1037/0022-006x.61.1.137 · Paper page
- 10.1037/0022-006x.56.5.748 · doi:10.1037/0022-006x.56.5.748 · Paper page
- Scharf MB, 1994, J Clin Psychiatry, 55, 192
Cited by
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
“Patient-reported data were collected for nights 1, 15, 29, 43, and 44.”
Prescribed drugs containing nitrogen heterocycles: an overview
Heravi, M. M., & Zadsirjan, V. (2020) · RSC Advances · doi:10.1039/d0ra09198g · Cited by 1,194
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“282,285 CBT-I can also lead to sustained remission of insomnia-related disorders, and continuous treatment of insomnia with CBT-I can also reduce the occurrence and recurrence of MDD. 286 Circadian rhythm support (CRS) can strengthen the circadian rhythm by means of scheduled bright light exposure,…”
BackgroundDepression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment
Fang, H., Tu, S., Sheng, J., & Shao, A. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14170 · Cited by 1,141
Insomnia as a predictor of mental disorders: a systematic review and meta-analysis
Hertenstein, E., Feige, B., Gmeiner, T., Kienzler, C., Spiegelhalder, K., Johann, A., Jansson-Fröjmark, M., Palagini, L., Rücker, G., Riemann, D., et al. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.10.006 · Cited by 1,201
Sleep, insomnia, and depression
Riemann, D., Krone, L. B., Wulff, K., & Nissen, C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 819
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., Bastien, C., Berzina, N., Bjorvatn, B., Dikeos, D., et al. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14035 · Cited by 834
“This antagonism seems to have been reconciled over the last decade (see guidelines/summaries by Quaseem et al., 2016; Wilson et al., 2019; Edinger et al., 2021), and is reflected by the wide authorship of this guideline.”
BackgroundInsomnia in the Elderly: A Review
Patel, D., Steinberg, J., & Patel, P. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7172 · Cited by 667
Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis
van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.02.001 · Cited by 676
Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L.-M., Nickless, A., Harrison, P. J., Emsley, R., Luik, A. I., Foster, R. G., Wadekar, V., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30328-0 · Cited by 652
Sleep is essential to health: an American Academy of Sleep Medicine position statement
Ramar, K., Malhotra, R. K., Carden, K. A., Martin, J. L., Abbasi-Feinberg, F., Aurora, R. N., Kapur, V. K., Olson, E. J., Rosen, C. L., Rowley, J. A., et al. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9476 · Cited by 648
Implications of sleep disturbance and inflammation for Alzheimer's disease dementia
Irwin, M. R., & Vitiello, M. V. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30450-2 · Cited by 578
Effects of Antidepressants on Sleep
Wichniak, A., Wierzbicka, A., Walęcka, M., & Jernajczyk, W. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0816-4 · Cited by 557
Sleep and anxiety: From mechanisms to interventions
Chellappa, S. L., & Aeschbach, D. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101583 · Cited by 509
Rusch, H. L., Rosario, M., Levison, L. M., Olivera, A., Livingston, W. S., Wu, T., & Gill, J. M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13996 · Cited by 500
Blake, M. J., Trinder, J. A., & Allen, N. B. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.05.006 · Cited by 443
Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., Cape, J., Ong, J. C., Sheaves, B., Foster, R., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2745 · Cited by 466
Perlis, M. L., Posner, D., Riemann, D., Bastien, C. H., Teel, J., & Thase, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00879-0 · Cited by 395
Insomnia disorder: State of the science and challenges for the future
Riemann, D., Benz, F., Dressle, R. J., Espie, C. A., Johann, A. F., Blanken, T. F., Leerssen, J., Wassing, R., Henry, A. L., Kyle, S. D., et al. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13604 · Cited by 343
“These guidelines include the American College of Physicians (Brasure et al., 2016; Kathol & Arnedt, 2016; Qaseem et al., 2016; Wilt et al., 2016), the American Academy of Sleep Medicine (AASM; Edinger et al., 2021a, b), the German and the European Sleep Society (Riemann, Baum, et al., 2017;…”
BackgroundHertenstein, E., Trinca, E., Wunderlin, M., Schneider, C. L., Züst, M. A., Fehér, K. D., Su, T., Straten, A. V., Berger, T., Baglioni, C., et al. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101597 · Cited by 391
Koffel, E., Bramoweth, A. D., & Ulmer, C. S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4390-1 · Cited by 391
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373
Johnson, D. A., Jackson, C. L., Williams, N., & Alcántara, C. (2019) · Nature and Science of Sleep · doi:10.2147/nss.s169312 · Cited by 357
Riemann, D., Baum, E., Cohrs, S., Crönlein, T., Hajak, G., Hertenstein, E., Klose, P., Langhorst, J., Mayer, G., Nissen, C., et al. (2017) · Somnologie · doi:10.1007/s11818-016-0097-x · Cited by 340
Benzodiazepine Use and Misuse Among Adults in the United States
Maust, D. T., Lin, L. A., & Blow, F. C. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800321 · Cited by 337
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
Backgroundvan der Zweerde, T., Bisdounis, L., Kyle, S. D., Lancee, J., & van Straten, A. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.08.002 · Cited by 336
Bair, M. J., & Krebs, E. E. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202003030 · Cited by 298
Murphy, P., Moline, M., Mayleben, D., Rosenberg, R., Zammit, G., Pinner, K., Dhadda, S., Hong, Q., Giorgi, L., & Satlin, A. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6800 · Cited by 329
Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C., Quigg, M. S., Cohn, W. F., & Morin, C. M. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3249 · Cited by 325
Wilson, S., Anderson, K., Baldwin, D., Dijk, D.-J., Espie, A., Espie, C., Gringras, P., Krystal, A., Nutt, D., Selsick, H., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855343 · Cited by 312
Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., et al. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8988 · Cited by 309
“Recent guidelines and statements that address comprehensive treatment for chronic insomnia uniformly support the use of cognitivebehavioral therapies (CBTs) as first-line treatment for the disorder.(34,35,37,38) A report from the American College of Physicians(34) recommended that all adult patients receive CBT for in…”
Sutton, E. L. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202103160 · Cited by 284
Mignot, E., Mayleben, D., Fietze, I., Leger, D., Zammit, G., Bassetti, C. L. A., Pain, S., Kinter, D. S., & Roth, T. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00436-1 · Cited by 255
Baglioni, C., Altena, E., Bjorvatn, B., Blom, K., Bothelius, K., Devoto, A., Espie, C. A., Frase, L., Gavriloff, D., Tuuliki, H., et al. (2020) · Journal of Sleep Research · doi:10.1111/jsr.12967 · Cited by 259
The assessment and management of insomnia: an update
Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019) · World Psychiatry · doi:10.1002/wps.20674 · Cited by 256
Sweetman, A., Lack, L., & Bastien, C. (2019) · Brain Sciences · doi:10.3390/brainsci9120371 · Cited by 253
“CBTi is the recommended ‘first line’ treatment for insomnia, and appears to be effective in the presence of co-morbid OSA [8,9,52].”
BackgroundDeprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.
(2018) · Europe PMC (PubMed Central) · Cited by 250
Effect of insomnia treatments on depression: A systematic review and meta-analysis
Gebara, M. A., Siripong, N., DiNapoli, E. A., Maree, R. D., Germain, A., Reynolds, C. F., Kasckow, J. W., Weiss, P. M., & Karp, J. F. (2018) · Depression and Anxiety · doi:10.1002/da.22776 · Cited by 247
“However, the American College of Physicians (Qaseem et al., 2016), the American Academy of Sleep Medicine (Schutte-Rodin et al., 2008), and the National Institute of Health (National Institutes of Health, 2005) recommend non-pharmacological treatment options as the first-line treatment of insomnia.”
BackgroundExercise can improve sleep quality: A systematic review and meta-analysis
Banno, M., Harada, Y., Taniguchi, M., Tobita, R., Tsujimoto, H., Tsujimoto, Y., Kataoka, Y., & Noda, A. (2018) · PeerJ · doi:10.7717/peerj.5172 · Cited by 246
Systematic Review and Meta-analysis of Adolescent Cognitive–Behavioral Sleep Interventions
Blake, M. J., Sheeber, L. B., Youssef, G. J., Raniti, M. B., & Allen, N. B. (2017) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-017-0234-5 · Cited by 242
“The American College of Physicians recently recommended that all adult patients should receive CBT-I as an initial treatment for chronic insomnia (Qaseem et al. 2016).”
BackgroundParadoxical insomnia and subjective-objective sleep discrepancy: a review
Rezaie, L., Fobian, A. D., McCall, W. V., & Khazaie, H. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.01.002 · Cited by 236
Pigeon, W. R., Bishop, T. M., & Krueger, K. M. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0802-x · Cited by 233
Sleep and circadian rhythm in response to the COVID-19 pandemic
Morin, C. M., Carrier, J., Bastien, C., Godbout, R., & On behalf of the Canadian Sleep and Circadian Network (2020) · Canadian Journal of Public Health · doi:10.17269/s41997-020-00382-7 · Cited by 220
“Evidence-based treatment options for the clinical management of insomnia include hypnotic medications and cognitive behavioural therapy (Qaseem et al. 2016).”
BackgroundRichards, A., Kanady, J. C., & Neylan, T. C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0486-5 · Cited by 200
“The profound value of these models and testimony to their validity is that the CBT-I that is based on these models is the first-line therapy for insomnia disorder, with proven efficacy in insomnia alone and comorbid with a multitude of psychiatric and medical conditions [170, 171].”
BackgroundKalmbach, D. A., Arnedt, J. T., Song, P. X., Guille, C., & Sen, S. (2017) · Sleep · doi:10.1093/sleep/zsw073 · Cited by 202
Zachariae, R., Amidi, A., Damholdt, M. F., Clausen, C. D. R., Dahlgaard, J., Lord, H., Thorndike, F. P., & Ritterband, L. M. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx293 · Cited by 212
“Cognitive-behavioral therapy for insomnia (CBT-I) (11) is an efficacious nonpharmacological alternative (12,13) and is the recommended first-choice treatment for chronic insomnia (14).”
BackgroundSelvanathan, J., Pham, C., Nagappa, M., Peng, P. W. H., Englesakis, M., Espie, C. A., Morin, C. M., & Chung, F. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101460 · Cited by 206
Bi-directional relationships between co-morbid insomnia and sleep apnea (COMISA)
Sweetman, A., Lack, L., McEvoy, R. D., Smith, S., Eckert, D. J., Osman, A., Carberry, J. C., Wallace, D., Nguyen, P. D., & Catcheside, P. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101519 · Cited by 203
Irwin, M. R., Carrillo, C., Sadeghi, N., Bjurstrom, M. F., Breen, E. C., & Olmstead, R. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.3422 · Cited by 203
Sleep Monitoring in Athletes: Motivation, Methods, Miscalculations and Why It Matters
Halson, S. L. (2019) · Sports Medicine · doi:10.1007/s40279-019-01119-4 · Cited by 145
Garland, S. N., Xie, S. X., DuHamel, K., Bao, T., Li, Q., Barg, F. K., Song, S., Kantoff, P., Gehrman, P., & Mao, J. J. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz050 · Cited by 193
“Despite recognition of CBT-I as the gold standard and first-line therapy (5,28,29), systematic dissemination and implementation efforts are required to make CBT-I available to patients from diverse backgrounds and those who live in more rural communities.”
BackgroundAlimoradi, Z., Jafari, E., Broström, A., Ohayon, M. M., Lin, C.-Y., Griffiths, M. D., Blom, K., Jernelöv, S., Kaldo, V., & Pakpour, A. H. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101646 · Cited by 176
Cheng, P., Luik, A. I., Fellman-Couture, C., Peterson, E., Joseph, C. L. M., Tallent, G., Tran, K. M., Ahmedani, B. K., Roehrs, T., Roth, T., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001113 · Cited by 184
Furukawa, Y., Sakata, M., Yamamoto, R., Nakajima, S., Kikuchi, S., Inoue, M., Ito, M., Noma, H., Takashina, H. N., Funada, S., et al. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.5060 · Cited by 164
Insomnia in Elderly Patients: Recommendations for Pharmacological Management
Abad, V. C., & Guilleminault, C. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0569-8 · Cited by 174
Sleep disorders in early psychosis: incidence, severity, and association with clinical symptoms
Reeve, S., Sheaves, B., & Freeman, D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby129 · Cited by 182
Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4491 · Cited by 172
Effects of Tai Chi or Exercise on Sleep in Older Adults With Insomnia: A Randomized Clinical Trial
Siu, P. M., Yu, A. P., Tam, B. T., Chin, E. C., Yu, D. S., Chung, K.-F., Hui, S. S., Woo, J., Fong, D. Y., Lee, P. H., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37199 · Cited by 159
Mitchell, L. J., Bisdounis, L., Ballesio, A., Omlin, X., & Kyle, S. D. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.06.002 · Cited by 171
“[13], despite cognitive behavioural therapy for insomnia (CBT-I) being recommended as the first-line treatment in clinical guidelines [14-16].”
MethodMorin, C. M., & Buysse, D. J. (2024) · New England Journal of Medicine · doi:10.1056/nejmcp2305655 · Cited by 189
Cheng, P., Kalmbach, D. A., Tallent, G., Joseph, C. L., Espie, C. A., & Drake, C. L. (2019) · Sleep · doi:10.1093/sleep/zsz150 · Cited by 154
Theorell-Haglöw, J., Miller, C. B., Bartlett, D. J., Yee, B. J., Openshaw, H. D., & Grunstein, R. R. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.03.003 · Cited by 161
Sleep and schizophrenia: From epiphenomenon to treatable causal target
Waite, F., Sheaves, B., Isham, L., Reeve, S., & Freeman, D. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.014 · Cited by 149
Sex differences in sleep, circadian rhythms, and metabolism: Implications for precision medicine
Lok, R., Qian, J., & Chellappa, S. L. (2024) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2024.101926 · Cited by 183
Digital Cognitive Behavioral Therapy (dCBT) for Insomnia: a State-of-the-Science Review
Luik, A. I., Kyle, S. D., & Espie, C. A. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0065-4 · Cited by 157
Kline, C. E., Hillman, C. H., Sheppard, B. B., Tennant, B., Conroy, D. E., Macko, R. F., Márquez, D. X., Petruzzello, S. J., Powell, K. E., & Erickson, K. I. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101489 · Cited by 169
Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial
McCall, W. V., Benca, R. M., Rosenquist, P. B., Youssef, N. A., McCloud, L., Newman, J. C., Case, D., Rumble, M. E., Szabo, S. T., Phillips, M., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19030267 · Cited by 157
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
Dauvilliers, Y. A., Zammit, G. K., Fietze, I., Mayleben, D. W., Kinter, D. S., Pain, S., & Hedner, J. A. (2020) · Annals of Neurology · doi:10.1002/ana.25680 · Cited by 162
A randomized controlled trial of digital cognitive behavioral therapy for insomnia in pregnant women
Kalmbach, D. A., Cheng, P., O'Brien, L. M., Swanson, L. M., Sangha, R., Sen, S., Guille, C., Cuamatzi-Castelan, A., Henry, A. L., Roth, T., et al. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.03.016 · Cited by 154
“Cognitive-behavioral therapy for insomnia (CBTI), the guideline recommended treatment for insomnia [23], is highly effective and confers benefits over pharmacotherapy including superior long-term insomnia outcomes [24,25].”
BackgroundInterventions for sleep problems during pregnancy: A systematic review
Bacaro, V., Benz, F., Pappaccogli, A., De Bartolo, P., Johann, A. F., Palagini, L., Lombardo, C., Feige, B., Riemann, D., & Baglioni, C. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101234 · Cited by 145
Efficacy of cognitive behavioral therapy for insomnia in breast cancer: A meta-analysis
Ma, Y., Hall, D. L., Ngo, L. H., Liu, Q., Bain, P. A., & Yeh, G. Y. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101376 · Cited by 151
“DISCUSSION Cognitive behavioral therapy for insomnia (CBT-I) has been supported broadly as a gold standard non-pharmacological treatment for insomnia, including endorsement by the American College of Physicians as first line treatment [54].”
MethodKay, D., & Buysse, D. (2017) · Brain Sciences · doi:10.3390/brainsci7030023 · Cited by 143
“Cognitive behavioral therapy for insomnia (CBTI) is recommended as the first-line treatment for chronic insomnia [104,105].”
BackgroundCognitive Behavioral Therapy for Prenatal Insomnia: A Randomized Controlled Trial
Manber, R., Bei, B., Simpson, N., Asarnow, L., Rangel, E., Sit, A., & Lyell, D. (2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003216 · Cited by 145
Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis
Kuriyama, A., & Tabata, H. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.09.004 · Cited by 155
Simon, L., Steinmetz, L., Feige, B., Benz, F., Spiegelhalder, K., & Baumeister, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-28853-0 · Cited by 132
The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice
Loddo, G., Buonaura, G. C., Sambati, L., Giannini, G., Cecere, A., Cortelli, P., & Provini, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00042 · Cited by 154
“If insomnia is not iatrogenic and not due to PD motor complications, the principal therapy remains the cognitive behavioral therapy (29, 30).”
BackgroundBenz, F., Knoop, T., Ballesio, A., Bacaro, V., Johann, A. F., Rücker, G., Feige, B., Riemann, D., & Baglioni, C. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101873 · Cited by 142
Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: A 10-year cohort
Zheng, B., Yu, C., Lv, J., Guo, Y., Bian, Z., Zhou, M., Yang, L., Chen, Y., Li, X., Zou, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008581 · Cited by 132
“Moreover, it is reasonable that insomnia symptoms are more modifiable and precisely targetable through behavioral therapies before developing into clinically significant insomnia disorder.(38) Therefore, future clinical trials or community-based intervention studies should be conducted to test whether lifestyle or sle…”
BackgroundKalmbach, D. A., Cheng, P., Arnedt, J. T., Anderson, J. R., Roth, T., Fellman-Couture, C., Williams, R. A., & Drake, C. L. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2018.11.019 · Cited by 131
Sleep Disorder Diagnosis During Pregnancy and Risk of Preterm Birth
Felder, J. N., Baer, R. J., Rand, L., Jelliffe-Pawlowski, L. L., & Prather, A. A. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002132 · Cited by 139
Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies
Bawany, F., Northcott, C. A., Beck, L. A., & Pigeon, W. R. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.12.007 · Cited by 231
Ho, Y.-T., Tsai, Y.-C., Kuo, T. B. J., & Yang, C. C. H. (2021) · Nutrients · doi:10.3390/nu13082820 · Cited by 130
“Cognitive behavioral therapy for insomnia (CBT-I) is regarded as the non-medical treatment that best improves sleep quality and is the first-line treatment for chronic insomnia, with an efficacy that is unquestionable [15].”
BackgroundFernandez, R., Moore, V., Van Ryswyk, E., Varcoe, T., Rodgers, R., March, W., Moran, L., Avery, J., McEvoy, D., & Davies, M. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s127475 · Cited by 137
Hasan, F., Tu, Y.-K., Yang, C.-M., James Gordon, C., Wu, D., Lee, H.-C., Yuliana, L. T., Herawati, L., Chen, T.-J., & Chiu, H.-Y. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101567 · Cited by 137
Riemann, D. W., Dressle, R. J., Benz, F., Spiegelhalder, K., Johann, A. F., Nissen, C., Hertenstein, E., Baglioni, C., Palagini, L., Krone, L. B., et al. (2024) · Journal of Sleep Research · doi:10.1111/jsr.14252 · Cited by 152
“Most recent insomnia guidelines for the USA, Germany and Europe (Qaseem et al., 2016; Riemann, Baglioni, et al., 2017; Riemann, Baum, et al., 2017; Riemann, Espie, et al., 2023) acknowledged the importance and increasing health burden of insomnia, and recommend a thorough differential-diagnostic procedure followed by…”
Yue, J.-L., Chang, X.-W., Zheng, J.-W., Shi, L., Xiang, Y., Que, J., Yuan, K., Teng, T., Teng, T., Li, Y., et al. (2023) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2023.101746 · Cited by 137
The orexin story and orexin receptor antagonists for the treatment of insomnia
Muehlan, C., Roch, C., Vaillant, C., & Dingemanse, J. (2023) · Journal of Sleep Research · doi:10.1111/jsr.13902 · Cited by 137
“Current treatment guidelines recommend cognitive behavioural therapy for insomnia (CBT-I) as the first-line treatment of insomnia (Qaseem et al., 2016; Riemann et al., 2017).”
BackgroundSleep Abnormalities in Schizophrenia: State of the Art and Next Steps
Ferrarelli, F. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20070968 · Cited by 148
Non-pharmacological Approaches for Management of Insomnia
Chan, N. Y., Chan, J. W. Y., Li, S. X., & Wing, Y. K. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01029-2 · Cited by 135
Bai, W., Zhao, Y.-J., Cai, H. X., Sha, S., Zhang, Q., Lei, S., Lok, K.-I., Chow, I. H. I., Cheung, T. C. C., Su, Z., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.061 · Cited by 132
“Agents such as benzodiazepines (e.g., Estazolam, Temazepam) (Gooneratne and Vitiello, 2014; Qaseem et al., 2016; Schroeck et al., 2016) and nonbenzodiazepines (e.g., eszopiclone) (Smagula et al., 2016) are effective in improving sleep-maintenance insomnia in this context.”
Arnedt, J. T., Conroy, D. A., Mooney, A., Furgal, A., Sen, A., & Eisenberg, D. (2021) · Sleep · doi:10.1093/sleep/zsaa136 · Cited by 109
Sleep Issues in Parkinson's Disease and Their Management
Zuzuárregui, J. R. P., & During, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00938-y · Cited by 124
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
Kunz, D., Dauvilliers, Y., Benes, H., García-Borreguero, D., Plazzi, G., Seboek Kinter, D., Coloma, P., Rausch, M., Sassi-Sayadi, M., & Thein, S. (2023) · CNS Drugs · doi:10.1007/s40263-022-00980-8 · Cited by 107
“Nevertheless, because of a lack of evidence and remaining safety concerns, sedative hypnotics remain recommended only for short-term use [2, 11, 22].”
BackgroundBlake, M., Waloszek, J. M., Schwartz, O., Raniti, M., Simmons, J. G., Blake, L., Murray, G., Dahl, R. E., Bootzin, R., Dudgeon, P., et al. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000142 · Cited by 114
Recent Advancements in Treating Sleep Disorders in Co-Occurring PTSD
Colvonen, P. J., Straus, L. D., Stepnowsky, C., McCarthy, M. J., Goldstein, L. A., & Norman, S. B. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0916-9 · Cited by 113
Drake, C. L., Kalmbach, D. A., Arnedt, J. T., Cheng, P., Tonnu, C. V., Cuamatzi-Castelan, A., & Fellman-Couture, C. (2019) · Sleep · doi:10.1093/sleep/zsy217 · Cited by 103
Wickwire, E. M., Schnyer, D. M., Germain, A., Smith, M. T., Williams, S. G., Lettieri, C. J., McKeon, A. B., Scharf, S. M., Stocker, R., Albrecht, J., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5243 · Cited by 103
Zhou, E. S., Ritterband, L. M., Bethea, T. N., Robles, Y. P., Heeren, T. C., & Rosenberg, L. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.0653 · Cited by 110
Okajima, I., Miyamoto, T., Ubara, A., Omichi, C., Matsuda, A., Sumi, Y., Matsuo, M., Ito, K., & Kadotani, H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238789 · Cited by 122
“Currently, cognitive behavioral therapy (CBT-I) is recommended as a treatment for chronic insomnia [4,7].”
BackgroundMethod
Metadata
- Authors
- Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians*
- Affiliations
- University of California, San Francisco (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2016-07-19
- Volume
- 165
- Issue
- 2
- Pages
- 125-133
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2347166707
- Cited by
- 1,965
- References
- 74
- Citations by year
- 2026: 201 · 2025: 227 · 2024: 216 · 2023: 252 · 2022: 227 · 2021: 222 · 2020: 210 · 2019: 156 · 2018: 121 · 2017: 101 · 2016: 27
- FWCI
- 191.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- chronic insomnia, cognitive behavioral therapy for insomnia, insomnia pharmacotherapy, shared decision-making, sleep medicine, adults, treatment guidelines
- MeSH terms
- Adult, Decision Making, Humans, Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy, Drug Costs, Risk Assessment, Comparative Effectiveness Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.